Furthermore, LCN2-deficiency attenuated aging- and obesity-induced insulin resistance by inhibiting 12-lipoxygenase, an enzyme that metabolizes arachidonic acids, and tumor necrosis factor-α (TNF-α), a critical insulin resistance inducer [118]. This evidence concerns the gene ALOX12 and Insulin resistance.